COM:KALVISTA
KalVista Pharmaceuticals
- Stock
Last Close
9.32
22/11 21:00
Market Cap
530.31M
Beta: -
Volume Today
405.00K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Apr '16 | Apr '17 | Apr '18 | Apr '19 | Apr '20 | Apr '21 | Apr '22 | Apr '23 | Apr '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.35M - | 1.35M 0% | ||||||||||
average payables | 304.50K - | 743K 144.01% | 1.02M 36.74% | 1.08M 6.35% | 1.29M 19.67% | 2.15M 66.01% | 2.27M 5.68% | 1.83M 19.37% | 2.81M 53.61% | 4.23M 50.47% | 6.96M 64.68% | |
average receivables | 1.12M - | 2.39M 113.76% | 4.69M 96.01% | 9.07M 93.47% | 13.92M 53.41% | 13.47M 3.22% | 12.26M 9.01% | 15.33M 25.09% | 13.72M 10.52% | |||
book value per share | -46.51 - | -167.76 260.72% | 36.35 121.67% | 6.74 81.46% | 2.64 60.84% | 6.41 142.95% | 4.72 26.44% | 13.47 185.45% | 7.56 43.85% | 5.77 23.66% | 5.62 2.73% | |
capex per share | -0.02 - | -0.47 1,811.21% | -0.02 96.08% | -0.02 14.40% | -0.14 768.14% | -0.07 48.15% | -0.01 82.71% | -0.00 65.35% | -0.04 785.84% | -0.04 12.72% | -0.01 71.92% | |
capex to depreciation | -0.67 - | -3.29 393.42% | -0.33 89.87% | -1.85 455.00% | -7.93 328.53% | -2.86 63.93% | -0.43 84.97% | -0.15 64.46% | -1.65 981.01% | -1.67 0.91% | -0.54 67.41% | |
capex to operating cash flow | 0.00 - | 0.02 429.78% | 0.00 95.74% | 0.00 273.09% | -0.14 4,432.73% | 0.03 121.99% | 0.00 83.49% | 0.00 44.64% | 0.01 338.42% | 0.02 33.37% | 0.00 68.76% | |
capex to revenue | -0.04 - | -0.07 59.75% | -0.01 92.56% | -0.05 854.07% | -0.17 245.52% | -0.07 60.57% | -0.02 74.14% | -0.01 62.73% | ||||
cash per share | 13.49 - | 14.80 9.65% | 36.81 148.74% | 6.66 81.90% | 4.95 25.74% | 6.68 35.14% | 3.82 42.93% | 13.04 241.71% | 6.79 47.91% | 5.36 21.14% | 5.72 6.79% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 4.07K - | |||||||||||
days sales outstanding | 383.14 - | 618.12 61.33% | 297.17 51.92% | 256.09 13.82% | 475.36 85.62% | 299.65 36.96% | ||||||
debt to assets | 0.30 - | 0.99 226.03% | -0.00 100.12% | 0.00 - | 0.00 89.94% | 0.02 3,789.21% | 0.02 22.19% | 0.04 84.88% | 0.04 11.89% | 0.03 30.83% | ||
debt to equity | -0.09 - | -0.15 63.55% | -0.00 99.09% | 0.01 - | 0.00 94.55% | 0.02 3,418.63% | 0.02 16.97% | 0.04 92.55% | 0.05 15.56% | 0.04 30.72% | ||
dividend yield | ||||||||||||
earnings yield | -0.10 - | -0.35 250.25% | -1.89 435.30% | -0.55 70.73% | -0.16 71.17% | -0.06 62.30% | -0.15 150.55% | -0.09 37.94% | -0.22 135.65% | -0.30 37.59% | -0.30 0.25% | |
enterprise value | 49.70M - | 23.17M 53.38% | -15.70M 167.78% | 2.74M 117.44% | 48.52M 1,671.41% | 314.91M 549.03% | 179.49M 43.00% | 432.11M 140.74% | 289.00M 33.12% | 199.39M 31.01% | 393.06M 97.13% | |
enterprise value over ebitda | -9.47 - | -2.88 69.62% | 0.93 132.46% | -0.12 112.39% | -2.86 2,373.55% | -10.68 273.05% | -4.53 57.61% | -7.42 63.93% | -3.06 58.79% | -1.81 40.85% | -2.65 46.76% | |
ev to operating cash flow | -10.23 - | -3.64 64.44% | 1.19 132.81% | -0.12 109.67% | 4.60 4,080.04% | -8.66 288.44% | -4.01 53.75% | -14.32 257.59% | -3.70 74.17% | -2.65 28.37% | -4.40 66.27% | |
ev to sales | 119.76 - | 12.84 89.28% | -7.36 157.32% | 1.82 124.74% | 5.78 217.39% | 19.53 237.82% | 14.14 27.56% | 34.05 140.74% | ||||
free cash flow per share | -6.73 - | -24.65 266.48% | -22.27 9.68% | -5.12 77.00% | 0.88 117.27% | -2.48 380.68% | -2.54 2.19% | -1.58 37.56% | -3.23 103.91% | -2.74 15.15% | -2.44 11.08% | |
free cash flow yield | -0.09 - | -0.32 266.48% | -2.17 585.90% | -0.71 67.49% | 0.09 113.02% | -0.11 217.40% | -0.23 115.44% | -0.06 72.72% | -0.25 299.97% | -0.31 21.78% | -0.21 30.51% | |
graham net net | -46.95 - | -178.19 279.50% | 34.15 119.17% | 6.42 81.20% | 2.14 66.74% | 5.83 172.92% | 4.02 31.05% | 12.67 215.25% | 6.51 48.61% | 5.01 23.11% | 5.16 3.03% | |
graham number | 90.54 - | 321.82 255.45% | 125.78 60.92% | 24.64 80.41% | 9.54 61.30% | 14.11 47.99% | 13.20 6.50% | 26.57 101.36% | 21.83 17.87% | 18.67 14.45% | 20.86 11.70% | |
income quality | 0.86 - | 0.88 3.00% | 1.15 30.54% | 1.28 10.85% | -0.67 152.39% | 1.75 361.52% | 1.54 11.89% | 0.65 57.61% | 0.95 45.45% | 0.81 14.63% | 0.70 13.02% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -12.88 - | 9.37 172.78% | 4.05 56.75% | 5.98 47.51% | 6.45 7.87% | 3.25 49.62% | -88.64 - | 6.17 106.96% | ||||
interest debt per share | 4.78 - | 21.65 352.58% | -6.38 129.47% | -0.80 87.40% | -0.25 68.42% | -0.60 138.23% | 0.09 115.32% | 0.31 233.89% | 0.38 22.51% | -0.35 192.04% | 0.20 157.00% | |
inventory turnover | ||||||||||||
invested capital | -0.09 - | -0.15 63.55% | -0.00 99.09% | 0.01 - | 0.00 94.55% | 0.02 3,418.63% | 0.02 16.97% | 0.04 92.55% | 0.05 15.56% | 0.04 30.72% | ||
market cap | 56.42M - | 20.50M 63.66% | 6.06M 70.43% | 33.69M 455.85% | 99.30M 194.74% | 346.86M 249.32% | 193.64M 44.17% | 476.79M 146.23% | 311.54M 34.66% | 247.39M 20.59% | 417.53M 68.77% | |
net current asset value | -33.90M - | -46.24M 36.38% | 21.42M 146.33% | 31.23M 45.78% | 25.24M 19.17% | 94.15M 272.97% | 79.92M 15.12% | 249.44M 212.12% | 174.86M 29.90% | 150.15M 14.13% | 196.87M 31.12% | |
net debt to ebitda | 1.28 - | -0.33 125.89% | 1.29 490.57% | 1.31 0.99% | 3.00 129.09% | 1.08 63.83% | 0.36 67.08% | 0.77 115.12% | 0.24 68.91% | 0.44 82.56% | 0.17 62.05% | |
net income per share | -7.83 - | -27.44 250.25% | -19.34 29.51% | -4.00 79.30% | -1.53 61.75% | -1.38 9.86% | -1.64 18.85% | -2.33 42.05% | -2.80 20.14% | -2.68 4.13% | -3.44 28.28% | |
operating cash flow per share | -6.70 - | -24.18 260.76% | -22.25 7.98% | -5.11 77.06% | 1.02 120.04% | -2.41 335.74% | -2.53 4.72% | -1.58 37.42% | -3.19 102.05% | -2.70 15.48% | -2.43 10.11% | |
payables turnover | 0.09 - | |||||||||||
receivables turnover | 0.95 - | 0.59 38.02% | 1.23 108.01% | 1.43 16.04% | 0.77 46.13% | 1.22 58.64% | ||||||
research and ddevelopement to revenue | 10.19 - | 4.59 54.93% | 6.87 49.66% | 8.42 22.52% | 2.17 74.20% | 2.17 0.05% | 3.17 45.86% | 3.25 2.72% | ||||
return on tangible assets | -0.56 - | -1.09 93.56% | -0.46 57.51% | -0.54 17.20% | -0.26 52.47% | -0.18 31.56% | -0.31 78.58% | -0.16 48.02% | -0.34 105.44% | -0.41 21.59% | -0.54 31.67% | |
revenue per share | 0.57 - | 6.85 1,096.36% | 3.61 47.34% | 0.32 91.03% | 0.81 151.26% | 1.07 31.50% | 0.71 33.14% | 0.66 7.05% | ||||
roe | 0.17 - | 0.16 2.90% | -0.53 425.28% | -0.59 11.62% | -0.58 2.34% | -0.22 62.90% | -0.35 61.56% | -0.17 50.24% | -0.37 113.96% | -0.46 25.59% | -0.61 31.88% | |
roic | 0.18 - | 0.19 2.88% | -0.37 296.91% | -0.52 38.74% | -0.62 19.10% | -0.31 49.73% | -0.46 49.70% | -0.21 55.32% | -0.40 92.60% | -0.50 26.13% | -0.65 29.66% | |
sales general and administrative to revenue | 3.38 - | 0.89 73.62% | 1.24 39.54% | 7.43 497.49% | 1.06 85.79% | 0.68 35.83% | 1.03 51.55% | 1.31 27.69% | ||||
shareholders equity per share | -46.51 - | -167.76 260.72% | 36.35 121.67% | 6.74 81.46% | 2.64 60.84% | 6.41 142.95% | 4.72 26.44% | 13.47 185.45% | 7.56 43.85% | 5.77 23.66% | 5.62 2.73% | |
stock based compensation to revenue | 0.57 - | 0.02 96.52% | 0.06 177.22% | 0.26 373.54% | 0.13 51.80% | 0.18 45.64% | 0.35 90.58% | 0.56 60.03% | ||||
tangible asset value | -33.71M - | -44.18M 31.07% | 21.50M 148.65% | 31.33M 45.73% | 27.25M 13.00% | 96.74M 254.96% | 83.75M 13.42% | 257.19M 207.09% | 185.09M 28.03% | 161.03M 13.00% | 206.58M 28.29% | |
tangible book value per share | -46.51 - | -167.76 260.72% | 36.35 121.67% | 6.74 81.46% | 2.64 60.84% | 6.41 142.95% | 4.72 26.44% | 13.47 185.45% | 7.56 43.85% | 5.77 23.66% | 5.62 2.73% | |
working capital | 5.96M - | -2.51M 142.05% | 21.42M 954.83% | 31.23M 45.78% | 36.16M 15.80% | 97.49M 169.59% | 80.98M 16.94% | 254.49M 214.28% | 182.07M 28.46% | 157.29M 13.61% | 202.88M 28.98% |
All numbers in USD (except ratios and percentages)